Tocilizumab as a possible cause of ischemic colitis.

Forneiro Pérez, RocíoDabán López, PabloZurita Saavedra, María SolHernández García, María DoloresMirón Pozo, Benito2023-02-092023-02-092020-11-13http://hdl.handle.net/10668/16602enAntibodies, Monoclonal, HumanizedCOVID-19Colitis, IschemicColonoscopyGastrointestinal HemorrhageHumansMaleMiddle AgedRectumCOVID-19 Drug TreatmentTocilizumab as a possible cause of ischemic colitis.Tocilizumab como posible causa de colitis isquémica.research article33190937open access10.1016/j.gastrohep.2020.07.0160210-5705PMC7661921https://doi.org/10.1016/j.gastrohep.2020.07.016https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661921/pdf